STX Financial Statements & Analysis
Complete financial statements for STX including income statement, balance sheet, and cash flow statement. Analyze STX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
70
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
38.9% ↑
Net Income
338.5% ↑
Gross Margin
50.0% ↑
Operating Margin
201.1% ↑
Balance Sheet
Current Ratio
28.3% ↑
Debt to Equity
-189.8% ↑
Asset Turnover
33.9% ↑
Cash Flow
Operating Cash Flow
18.0% ↑
Net Cash Flow
-181.6% ↓
Free Cash Flow
63.1% ↑
Cash Flow to Debt
34.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 6.55B | 9.10B | 38.9% | |
| Gross Profit | 1.54B | 3.20B | 108.3% | |
| Operating Income | 452.00M | 1.89B | 318.1% | |
| Net Income | 335.00M | 1.47B | 338.5% | |
| EPS | 1.6 | 6.93 | 333.1% | |
| EBITDA | 1.03B | 1.89B | 83.5% | |
| Gross Margin | 23.45% | 35.18% | 50.0% | |
| Operating Margin | 6.90% | 20.78% | 201.1% | |
| Net Income Margin | 5.11% | 16.15% | 215.8% | |
| R&D Expenses | 654.00M | 724.00M | 10.7% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 9.10B | 6.55B | 7.38B | 11.66B | 10.68B |
| Gross Profit | 3.20B | 1.54B | 1.35B | 3.47B | 2.92B |
| Operating Income | 1.89B | 452.00M | -342000000 | 1.96B | 1.49B |
| Net Income | 1.47B | 335.00M | -529000000 | 1.65B | 1.31B |
| EPS | 6.93 | 1.6 | -2.56 | 7.5 | 5.43 |
| EBITDA | 1.89B | 1.03B | 301.00M | 2.41B | 1.90B |
| Gross Margin | 35.18% | 23.45% | 18.30% | 29.75% | 27.31% |
| Operating Margin | 20.78% | 6.90% | -4.63% | 16.77% | 13.97% |
| Net Income Margin | 16.15% | 5.11% | -7.16% | 14.14% | 12.30% |
| R&D Expenses | 724.00M | 654.00M | 797.00M | 941.00M | 903.00M |